Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Albitar

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Cancer Research|June 26, 1999
Autocrine interleukin-1beta production in leukemia: evidence for the involvement of mutated RASD M Beaupre, M Talpaz, F C Marini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
Analysis of Philadelphia chromosome-negative BCR-ABL-positive chronic myelogenous leukemia by hypermetaphase fluorescence in situ hybridizationD Seong, H M Kantarjian, M Albitar, et al.
Cytokines, Cellular & Molecular Therapy|January 21, 2000
The incidence of chromosome 9p21 abnormalities and deletions of tumor suppressor genes p15(INK4b)/p16(INK4a)/p14(ARF) in patients with acute lymphoblastic leukemiaS Faderl, Z Estrov, H M Kantarjian, et al.
Leukemia|March 13, 2001
Comparison of outcome in acute myelogenous leukemia patients with translocation (8;21) found by standard cytogenetic analysis and patients with AML1/ETO fusion transcript found only by PCR testingJ E Sarriera, M Albitar, Z Estrov, et al.
Blood|September 9, 2000
Angiogenesis in acute and chronic leukemias and myelodysplastic syndromesA Aguayo, H Kantarjian, T Manshouri, et al.
Blood|July 1, 1995
p16INK4A and p15INK4B gene deletions in primary leukemiasM A Haidar, X B Cao, T Manshouri, et al.
Leukemia|July 29, 2005
Having a higher blast percentage in circulation than bone marrow: clinical implications in myelodysplastic syndrome and acute lymphoid and myeloid leukemiasH M Amin, Y Yang, Y Shen, et al.
Leukemia|January 12, 2007
Levels of soluble HLA-I and beta2M in patients with acute myeloid leukemia and advanced myelodysplastic syndrome: association with clinical behavior and outcome of induction therapyM Albitar, M Johnson, K A Do, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemiaD A Thomas, J Cortes, S O'Brien, et al.
Leukemia & Lymphoma|May 16, 2000
Progressive multifocal leukoencephalopathy with concurrent Richter's syndromeE D Saad, D A Thomas, S O'Brien, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Cancer Research|June 26, 1999
Autocrine interleukin-1beta production in leukemia: evidence for the involvement of mutated RASD M Beaupre, M Talpaz, F C Marini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
Analysis of Philadelphia chromosome-negative BCR-ABL-positive chronic myelogenous leukemia by hypermetaphase fluorescence in situ hybridizationD Seong, H M Kantarjian, M Albitar, et al.
Cytokines, Cellular & Molecular Therapy|January 21, 2000
The incidence of chromosome 9p21 abnormalities and deletions of tumor suppressor genes p15(INK4b)/p16(INK4a)/p14(ARF) in patients with acute lymphoblastic leukemiaS Faderl, Z Estrov, H M Kantarjian, et al.
Leukemia|March 13, 2001
Comparison of outcome in acute myelogenous leukemia patients with translocation (8;21) found by standard cytogenetic analysis and patients with AML1/ETO fusion transcript found only by PCR testingJ E Sarriera, M Albitar, Z Estrov, et al.
Blood|September 9, 2000
Angiogenesis in acute and chronic leukemias and myelodysplastic syndromesA Aguayo, H Kantarjian, T Manshouri, et al.
Blood|July 1, 1995
p16INK4A and p15INK4B gene deletions in primary leukemiasM A Haidar, X B Cao, T Manshouri, et al.
Leukemia|July 29, 2005
Having a higher blast percentage in circulation than bone marrow: clinical implications in myelodysplastic syndrome and acute lymphoid and myeloid leukemiasH M Amin, Y Yang, Y Shen, et al.
Leukemia|January 12, 2007
Levels of soluble HLA-I and beta2M in patients with acute myeloid leukemia and advanced myelodysplastic syndrome: association with clinical behavior and outcome of induction therapyM Albitar, M Johnson, K A Do, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemiaD A Thomas, J Cortes, S O'Brien, et al.
Leukemia & Lymphoma|May 16, 2000
Progressive multifocal leukoencephalopathy with concurrent Richter's syndromeE D Saad, D A Thomas, S O'Brien, et al.
Pageof 10